These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 32628846)

  • 1. How Do Small Molecule Aggregates Inhibit Enzyme Activity? A Molecular Dynamics Study.
    Ghattas MA; Al Rawashdeh S; Atatreh N; Bryce RA
    J Chem Inf Model; 2020 Aug; 60(8):3901-3909. PubMed ID: 32628846
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative Molecular Dynamics Simulation of Aggregating and Non-Aggregating Inhibitor Solutions: Understanding the Molecular Basis of Promiscuity.
    Ghattas MA; Bryce RA; Al Rawashdah S; Atatreh N; Zalloum WA
    ChemMedChem; 2018 Mar; 13(6):500-506. PubMed ID: 29058775
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stoichiometry and physical chemistry of promiscuous aggregate-based inhibitors.
    Coan KE; Shoichet BK
    J Am Chem Soc; 2008 Jul; 130(29):9606-12. PubMed ID: 18588298
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Promiscuous aggregate-based inhibitors promote enzyme unfolding.
    Coan KE; Maltby DA; Burlingame AL; Shoichet BK
    J Med Chem; 2009 Apr; 52(7):2067-75. PubMed ID: 19281222
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protein Stability Effects in Aggregate-Based Enzyme Inhibition.
    Torosyan H; Shoichet BK
    J Med Chem; 2019 Nov; 62(21):9593-9599. PubMed ID: 31589047
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In silico investigations on the binding efficacy and allosteric mechanism of six different natural product compounds towards PTP1B inhibition through docking and molecular dynamics simulations.
    SarathKumar B; Lakshmi BS
    J Mol Model; 2019 Aug; 25(9):272. PubMed ID: 31451955
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A specific mechanism of nonspecific inhibition.
    McGovern SL; Helfand BT; Feng B; Shoichet BK
    J Med Chem; 2003 Sep; 46(20):4265-72. PubMed ID: 13678405
    [TBL] [Abstract][Full Text] [Related]  

  • 8. On 3LEZ, a deep-sea halophilic protein with in vitro class-a β-lactamase activity: molecular-dynamics, docking, and reactivity simulations.
    Pietra F
    Chem Biodivers; 2012 Dec; 9(12):2659-84. PubMed ID: 23255440
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stability and equilibria of promiscuous aggregates in high protein milieus.
    Coan KE; Shoichet BK
    Mol Biosyst; 2007 Mar; 3(3):208-13. PubMed ID: 17308667
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Screening in a spirit haunted world.
    Shoichet BK
    Drug Discov Today; 2006 Jul; 11(13-14):607-15. PubMed ID: 16793529
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Resolving the Atomistic Modes of Anle138b Inhibitory Action on Peptide Oligomer Formation.
    Matthes D; Gapsys V; Griesinger C; de Groot BL
    ACS Chem Neurosci; 2017 Dec; 8(12):2791-2808. PubMed ID: 28906103
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kinetic characterization of fragment binding in AmpC β-lactamase by high-throughput molecular simulations.
    Bisignano P; Doerr S; Harvey MJ; Favia AD; Cavalli A; De Fabritiis G
    J Chem Inf Model; 2014 Feb; 54(2):362-6. PubMed ID: 24444037
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure-based screening of inhibitors against KPC-2: designing potential drug candidates against multidrug-resistant bacteria.
    Danishuddin M; Khan A; Faheem M; Kalaiarasan P; Hassan Baig M; Subbarao N; Khan AU
    J Biomol Struct Dyn; 2014; 32(5):741-50. PubMed ID: 23600675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stable Colloidal Drug Aggregates Catch and Release Active Enzymes.
    McLaughlin CK; Duan D; Ganesh AN; Torosyan H; Shoichet BK; Shoichet MS
    ACS Chem Biol; 2016 Apr; 11(4):992-1000. PubMed ID: 26741163
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Investigation for antimicrobial resistance-modulating activity of diethyl malate and 1-methyl malate against beta-lactamase class A from Bacillus licheniformis by molecular dynamics, in vitro and in vivo studies.
    Mirzaie S; Najafi K; Hakhamaneshi MS; Shahverdi AR; Fathi F
    J Biomol Struct Dyn; 2015; 33(5):1016-26. PubMed ID: 24836845
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evolution of conformational dynamics determines the conversion of a promiscuous generalist into a specialist enzyme.
    Zou T; Risso VA; Gavira JA; Sanchez-Ruiz JM; Ozkan SB
    Mol Biol Evol; 2015 Jan; 32(1):132-43. PubMed ID: 25312912
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Binding properties of a peptide derived from beta-lactamase inhibitory protein.
    Rudgers GW; Huang W; Palzkill T
    Antimicrob Agents Chemother; 2001 Dec; 45(12):3279-86. PubMed ID: 11709298
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular dynamics simulation studies of novel β-lactamase inhibitor.
    Ul Haq F; Abro A; Raza S; Liedl KR; Azam SS
    J Mol Graph Model; 2017 Jun; 74():143-152. PubMed ID: 28432959
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Crystal structure of the IMP-1 metallo beta-lactamase from Pseudomonas aeruginosa and its complex with a mercaptocarboxylate inhibitor: binding determinants of a potent, broad-spectrum inhibitor.
    Concha NO; Janson CA; Rowling P; Pearson S; Cheever CA; Clarke BP; Lewis C; Galleni M; Frère JM; Payne DJ; Bateson JH; Abdel-Meguid SS
    Biochemistry; 2000 Apr; 39(15):4288-98. PubMed ID: 10757977
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inactivation of TEM-1 by avibactam (NXL-104): insights from quantum mechanics/molecular mechanics metadynamics simulations.
    Sgrignani J; Grazioso G; De Amici M; Colombo G
    Biochemistry; 2014 Aug; 53(31):5174-85. PubMed ID: 25050826
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.